ABOUT
Experienced leader in diverse multi-disciplinary companies, from medical devices to capital equipment.
Main career stops including:
Co-Founder and CEO @ Pentaomix (2021) : Pentaomix develops a system for cancer diagnostics that will enable a breakthrough in the ability of doctors to match cancer patients with the best drug. The system is based on hyper-spectral imaging and deep learning.
CEO @ GluSense (2011 > 2021): GluSense developed a long-term implantable glucose sensor based on an innovative combination of state-of-the-art biology and medical device technology. I lead the company from a very early stage, through product development and preclinical stages up to a clinical study.
VP R&D, CTO @ Nova Measuring Instruments (1999-2011): In Nova I lead the development of a 3D measurement system enabling process control of the finest details in semiconductor manufacturing, from the first patent through 5 product generations in the market.
Related companies